Europe’s press has again given wide-ranging coverage to the row between Britain and the EU over the supply of vaccines, with one paper saying that Boris Johnson’s “gamble” in getting a head-start on production had paid off. The EU has urged AstraZeneca to divert millions of doses from UK plants, but the British government has resisted those demands. Michael Gove, the Cabinet Office minister, told the BBC on Thursday: "The supplies that have been planned, paid for and scheduled should continue." Asked whether he would allow vaccines manufactured in the UK to be diverted to the EU, he said "no", adding that there must be no interruption to the British vaccination programme. AstraZeneca says it can only deliver the EU a fraction of the doses between now and March due to production problems at plants in Europe. De Standaard, a Belgian newspaper, said the success of the Prime Minister’s move was a source of great frustration to the French, in particular, who are lagging far behind in their vaccine programme. It suggested that Brexiteers would take heart from that because Paris had regularly taken a hardline stance in the Brexit negotiations. The Flemish newspaper said that Mr Johnson liked to take risks and in this case, as opposed to in Brexit, the gambit had worked. Another Belgian paper, Het Nieuwsblad, said the unprecedented public attacks by the European Commission were designed to bring AstraZeneca "to its knees". "These doses are crucial to give a long-awaited boost to slow European vaccination campaigns," the paper said. It quoted Hendrik Vos, a professor of European politics, who said the Commission wanted to prove the shortfall was not its fault.